electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York

Rhea-AI Summary

electroCore, Inc. (NASDAQ: ECOR) announced that its co-founder and Chief Medical Officer, Dr. Peter Staats, will keynote the Fifth Annual Bioelectronic Medicine Forum on April 5, 2022, in New York City. This event will focus on bioelectronic medicine technologies and their applications across various medical fields, including cardiovascular and gastrointestinal disorders. Dr. Staats holds significant leadership roles in multiple medical societies and is dedicated to advancing non-invasive vagus nerve stimulation therapy aimed at improving patient outcomes in treating migraine and cluster headaches.

Positive

• Dr. Peter Staats, a prominent figure in bioelectronic medicine, is keynoting an important industry forum.
• The forum will showcase diverse applications of bioelectronic technologies, potentially raising the company's profile.

Negative

• None.

ROCKAWAY, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced its co-founder and Chief Medical Officer, Dr. Peter Staats, will keynote the Fifth Annual Bioelectronic Medicine Forum on April 5, 2022.

The event will take place in New York City and will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

Other panelists and presenters at the 2022 event include Marom Biksom, Professor of Biomedical Engineering at City College of New York; Imran Eba, partner at Action Potential Venture Capital; and Eric Van Gieson, Ph.D., Program Manager at DARPA Biological Technologies Office; and prior keynote speakers include Murthy Simhambhatla, the President and CEO of SetPoint Medical.

Dr. Staats is the former President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society. He is currently President of the World Institute of Pain and continues to serve as Chief Medical Officer for National Spine and Pain Centers, the largest pain practice in the United States, and electroCore, Inc.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital

FAQ

What is electroCore's participation in the Bioelectronic Medicine Forum?

electroCore's co-founder and Chief Medical Officer, Dr. Peter Staats, will be the keynote speaker at the Fifth Annual Bioelectronic Medicine Forum on April 5, 2022.

What topics will be covered at the Bioelectronic Medicine Forum?

The forum will discuss various technologies in bioelectronic medicine, including applications in cardiovascular medicine and gastrointestinal disorders.

Who are the other notable speakers at the Bioelectronic Medicine Forum?

Other speakers include Marom Biksom, Imran Eba, and Eric Van Gieson, among others.

What is electroCore's primary focus in bioelectronic medicine?

electroCore focuses on non-invasive vagus nerve stimulation therapy for treating migraine and cluster headaches.